Prototype solutions for peripheral nerve injury

Ended Awarded Last action

Contract number
W81XWH1890009
Awardee
Awarding agency
Obligated
$7,307,350

Award facts

Contract value 100% obligated
$7,307,350.45 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Medical Command Department of the Army, Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Program Solicitation
Pricing
Other
Place of performance
Summerville, SC 29486, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00007 · Novel cell-based therapy to treat muscle atrophy; injectable GEL for restoration of myoneural function and accelerated innervation of 3D bioprinted muscle… $0
Supplemental Agreement for work within scope P00006 · Modification to extend the period of performance and update the SOW at no additional cost to the government. $0
Supplemental Agreement for work within scope P00005 $0
Supplemental Agreement for work within scope P00004 $0
Supplemental Agreement for work within scope P00003 $0
Supplemental Agreement for work within scope P00002 · Modification to extend the period of performance at no additional cost to the government. $0
Other Administrative Action P00001 · Modification to update payment terms. $0
Original award $7,307,350

About this award

This federal contract award, valued at $7,307,350.45, was granted to the Medical Technology Enterprise Consortium (MTEC), a non-profit organization that serves as a medical technology accelerator for the U.S. Department of Defense. The award is for the development of prototype solutions for peripheral nerve injury, including a novel cell-based therapy to treat muscle atrophy and an injectable gel for restoration of neuromuscular function and accelerated innervation of 3D bioprinted muscle constructs.

The contract is an Other Transaction Order (OTO) awarded by the U.S. Army Medical Command, a defense agency, with a performance location in Summerville, South Carolina. It does not have a set-aside designation. The award is associated with a larger Other Transaction Indefinite Delivery Vehicle (IDV) agreement between MTEC and the Defense Health Agency, valued at $3,466,511.50, focused on enabling nighttime austere resuscitative and surgical care using night vision technology. This IDV allows MTEC to rapidly prototype and field innovative medical products in support of military healthcare priorities and readiness missions.

Quick answers

Who was awarded contract W81XWH1890009?

W81XWH1890009 was awarded to Medical Technology Enterprise Consortium by Defense Health Agency (Department of Defense) on September 28, 2018.

How much is contract W81XWH1890009 worth?

The government has obligated $7,307,350 on W81XWH1890009.

Which agency awarded contract W81XWH1890009?

Defense Health Agency (Department of Defense) awarded W81XWH1890009, with funding from Medical Command (Department of the Army).

Is contract W81XWH1890009 an order under another contract?

Yes. W81XWH1890009 is an other transaction order under W81XWH1590001, an other transaction IDV.

Was contract W81XWH1890009 competed?

The extent of competition for W81XWH1890009 was competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award